Dalbavancin is a novel antimicrobial against Gram-positive pathogens: clinical experience beyond labelled indications
FI: 0,892
Tipo: Article
Colaboración
Año: 2020
Autores
Nunez-Nunez, M; Casas-Hidalgo, I; Garcia-Fumero, R; Vallejo-Rodriguez, I; Anguita-Santos, F; Hernandez-Quero, J; Cabeza-Barrera, J; Ruiz-Sancho, A
Revista
Título: EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE
Cuartil
- Q4
